Intel Stock Had Risen Over 400%. Why Sell $15 Billion of New Shares Now?
ภาษาไทย Español Português 한국어 简体中文 繁體中文 日本語 Tiếng Việt Bahasa Indonesia Монгол ئۇيغۇر تىلى العربية Русский हिन्दी

Intel Stock Had Risen Over 400%. Why Sell $15 Billion of New Shares Now?

Published on: 2026-08-11   
Updated on: 2026-08-11

INTC
Buy: -- Sell: --
Trade Now

Intel stock had risen more than 400% over the previous year before the latest selloff, giving the chipmaker a chance to raise $15 billion without issuing a large percentage of its existing share count. On Monday, INTC closed at $97.52, down more than 4% after the proposed offering raised dilution concerns. Intel says the proceeds may fund capital expenditure and working capital as its 2026 capex rises above $20 billion, with total debt already at $50.5 billion and Intel Foundry still reporting multibillion-dollar losses.


Key Takeaways

  • A $15 billion offering at Intel’s $97.52 Monday close would equal roughly 154 million shares, about 3% of its 5.04 billion June-end share count. The final figure depends on the offering price.

  • Intel raised expected 2026 capex from $18 billion to more than $20 billion as it adds manufacturing capacity amid demand that has exceeded available supply.

  • Intel Foundry generated $5.77 billion of Q2 segment revenue and a $2.09 billion operating loss, while external revenue was only $293 million.

  • Intel ended Q2 with roughly $29.7 billion of cash and short-term investments against $50.5 billion of total debt, limiting the appeal of funding another large expansion entirely through borrowing.

  • Intel officially proposed a $15 billion offering, although Bloomberg reported it could rise toward $20 billion after orders reportedly exceeded $100 billion. Reuters could not independently verify that report.

Intel Chip and Rising Tech.png


Intel Can Raise $15 Billion With About 3% More Shares

Intel’s August 10 preliminary prospectus proposes a $15 billion common-stock offering and gives underwriters a 30-day option to purchase another $2.25 billion. The filing still leaves the public offering price and exact number of shares blank.


Intel had approximately 5.04 billion shares outstanding at the end of Q2. Using Monday’s $97.52 close only as an illustration, $15 billion would require roughly 154 million shares, increasing the June-end share count by about 3%. The final percentage will depend on where the offering is priced.


The timing follows an extraordinary rally. Intel had increased roughly fivefold over the preceding year before Monday’s decline, making equity far less dilutive than it would have been before the run-up.


Bloomberg reported late Monday that investor orders had exceeded $100 billion and Intel was considering increasing the offering toward $20 billion at $95 per share or higher. Reuters could not verify the report, and Intel’s latest SEC filing still lists the official proposed offering at $15 billion.


Why Has Intel Pushed Capex Above $20 Billion?

Intel raised its 2026 capital-spending forecast from $18 billion to more than $20 billion in July and expects spending to rise further next year. Management has linked the increase to stronger customer demand and additional investment in equipment, clean-room space and substrates.


The growth is already visible in Intel’s Data Centre and AI business. DCAI revenue increased 59% year over year to $6.26 billion in Q2, while operating income climbed from $633 million to $2.47 billion.


Intel is also expanding manufacturing capacity and advanced packaging while progressing newer process technologies. The company has said customers continue to signal strong demand driven by AI compute, including opportunities across purpose-built silicon, advanced packaging and external wafers.


The growth gives Intel a reason to add capacity. Whether that spending earns an adequate return is the harder question.


Intel Foundry Lost $2.1 Billion in Q2

Intel Foundry reported $5.77 billion of Q2 segment revenue, up from $4.42 billion a year earlier. Its operating loss narrowed from $3.17 billion to $2.09 billion.


Most of that revenue still comes from work performed for Intel’s own product businesses. External foundry, assembly and test revenue was only $293 million during the quarter.


That external figure also needs context. Intel said most of the year-over-year increase came from Altera becoming an external customer after its deconsolidation in 2025, rather than solely from new third-party foundry wins.


Intel is raising capital even though its external Foundry business is still small and the segment is still losing money. For the spending to pay off, Intel needs higher utilisation, more outside customers and better margins.


Why Intel Chose Equity Over More Debt

At the end of Q2, Intel had $12.87 billion in cash and $16.85 billion in short-term investments, or about $29.7 billion combined. Total debt stood at $50.5 billion, up from $46.6 billion at the end of 2025.


Debt also rose after Intel paid $14.2 billion to buy Apollo’s minority stake in its Ireland manufacturing joint venture, partly financed with a $6.5 billion term loan that was later refinanced with senior notes.


Another $15 billion of debt would increase leverage and interest expense as Intel's capital budget rises. Equity avoids another fixed payment obligation, but existing shareholders absorb the cost through dilution.


Intel said the offering could fund capital expenditure and working capital while helping preserve its balance sheet and investment-grade rating.


What Intel Needs to Prove Next

Three numbers can change how the $15 billion raise looks from here.


  • External Foundry revenue: Q2 external revenue was only $293 million against $5.77 billion of total Foundry segment revenue, and much of the increase came from Altera’s reclassification. Genuine third-party business now needs to grow.

  • Foundry losses: The Q2 operating loss narrowed from $3.17 billion to $2.09 billion. Further reductions would show that the manufacturing economics are improving.

  • Capital returns: Intel has pushed 2026 capex above $20 billion and expects substantially higher spending in 2027. That investment eventually needs to produce more cash and better manufacturing returns.


If those numbers fail to improve while spending keeps rising, Intel may need more outside capital even after this offering.


FAQs

Is Intel’s $15 billion stock offering already priced?

No. Intel’s latest preliminary prospectus still leaves the final public offering price and number of shares blank. The roughly 3% increase in share count discussed above uses Monday’s $97.52 closing price only as an illustration.


Could Intel raise more than $15 billion?

Yes. Intel’s official proposal includes a 30-day option allowing underwriters to buy up to another $2.25 billion of shares, which could take the announced deal to $17.25 billion. Bloomberg has separately reported that strong demand could push the offering toward $20 billion, although Reuters has not independently verified that report.


Does Intel’s share sale mean management thinks the stock is overvalued?

Intel has not said so. What the higher price does provide is a more favourable way to raise equity because the company can obtain billions in cash while issuing fewer shares than it would have needed at a lower valuation.


Could Intel issue more shares after this offering?

Yes. Future equity raises remain possible if Intel needs additional capital and chooses not to rely on cash or additional borrowing. Intel’s prospectus also warns that future stock or equity-linked issuance could dilute existing shareholders.


Intel Can Afford the Dilution. Now It Has to Justify It.

Intel is selling shares now because its fivefold rally makes equity relatively inexpensive in dilution terms while its capital needs are rising and debt already stands at $50.5 billion. That makes the offering a rational financing choice today. Whether it remains one depends on Intel turning more than $20 billion of annual capital spending into a Foundry business that needs less outside funding, not more.



Disclaimer: This material is for general information purposes only and is not intended as (and should not be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by EBC or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.